Graves' Disease Associated with Cerebrovascular Disease and Antiphospholipid Antibody Syndrome

Graves' Disease Associated with Cerebrovascular Disease and Antiphospholipid Antibody Syndrome

Saved in:

Bibliographic Details
Main Authors:	Ines Khochtali, Nadia Hamza, Elyes Gassab, Asma Baba, Maha Kacem, Mahbouba Frih, Sylvia Mahjoub
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2010/624152
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Screening of Antiphospholipid Antibodies in Obstetric Antiphospholipid Syndrome-Like Events: A Regional Perspective
by: Onder Onen, et al.
Published: (2020-12-01)

The cerebrovascular diseases
by: Miguel Angel Buergo Zuaznábar
Published: (2007-05-01)

The Potential of Antibodies Against the Phosphatidylserine / Prothrombin Complex as a Biomarker in Antiphospholipid Syndrome
by: Piotr Pasek, et al.
Published: (2025-02-01)

Thyrotoxicosis after COVID-19 Infection with a Delay in Graves’ Disease Antibody Positivity
by: Dennis C. Boyle, et al.
Published: (2023-01-01)

The Influence of Juvenile Graves’ Ophthalmopathy on Graves’ Disease Course
by: Jurate Jankauskiene, et al.
Published: (2017-01-01)

Catastrophic Antiphospholipid Syndrome
by: Rawhya R. El-Shereef, et al.
Published: (2016-01-01)

The Cerebrovascular Disease and Nutritional State.
by: Leticia del Rosario Cruz, et al.
Published: (2007-05-01)

A Pediatric Case of Cowden Syndrome with Graves’ Disease
by: Cláudia Patraquim, et al.
Published: (2017-01-01)

Visual and somatosensory evoked potentials abnormalities among Behçet’s disease patients and their relation to disease activity, severity and antiphospholipid antibodies: a cross-sectional study
by: Ghada S. Nageeb, et al.
Published: (2025-01-01)

Predictive Factors of Development of Graves’ Ophthalmopathy for Patients with Juvenile Graves’ Disease
by: Dalia Jarusaitiene, et al.
Published: (2016-01-01)

Auditory Dysfunction in Patients with Cerebrovascular Disease
by: Sadaharu Tabuchi
Published: (2014-01-01)

Abnormal Cerebrovascular Reactivity in Parkinson’s Disease
by: Kiran Prakash
Published: (2015-01-01)

SYSTOLIC HYPERTENSION. IMPACT ON CEREBROVASCULAR DISEASE
by: Juan Eloy Cruz Quesada, et al.
Published: (2011-08-01)

Clinic Practical Guides for Cerebrovascular Diseases
by: Miguel Angel Buergo Zuaznábar, et al.
Published: (2007-05-01)

Dysphagia in patients with cerebrovascular disease. Update.
by: Amarilis Barbié Rubiera, et al.
Published: (2009-03-01)

Abnormal Cerebrovascular Reactivity in Patients with Parkinson’s Disease
by: Carlos Henrique Ferreira Camargo, et al.
Published: (2015-01-01)

Relationship between Periodontitis and Ischemic Cerebrovascular Disease
by: Magda Pinilla Pérez, et al.
Published: (2024-03-01)

Clinical Practice Guidelines for Cerebrovascular Disease Treatment
by: Rubén Bembibre Taboada, et al.
Published: (2009-03-01)

Cardiovascular Risk Factors in the Antiphospholipid Syndrome
by: Felipe Freire da Silva, et al.
Published: (2014-01-01)

POTS and Antiphospholipid Syndrome: An Unlikely Association
by: Kalvin Zee, et al.
Published: (2021-01-01)

The Role of TLR4 on B Cell Activation and Anti-β2GPI Antibody Production in the Antiphospholipid Syndrome
by: Si Cheng, et al.
Published: (2016-01-01)

Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
by: Raquel Ruiz-García, et al.
Published: (2014-01-01)

Graves’ Disease Presenting with Complete Atrioventricular Block
by: Young Sil Eom, et al.
Published: (2020-01-01)

Complications and Mortality Characterization in Acute Ischemic Cerebrovascular Disease
by: Ricardo Leyva Tornés, et al.
Published: (2021-09-01)

The Presence of Antineutrophil Cytoplasmic Antibodies and Antiphospholipid Antibodies in Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A Case-Control Study among Sudanese Patients
by: Mohammed Shams Aldeen, et al.
Published: (2022-01-01)

Clinical Images: Osteonecrosis of the sternum in antiphospholipid syndrome
by: Madalyn Walsh, et al.
Published: (2025-01-01)

Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
by: Karthik Nath, et al.
Published: (2018-01-01)

Antiphospholipid Syndrome Associated with Nonradiographic Axial Spondyloarthritis
by: Jozélio Freire De Carvalho, et al.
Published: (2021-01-01)

Primary Adrenal Failure due to Antiphospholipid Syndrome
by: Murat Sahin, et al.
Published: (2015-01-01)

Secondary antiphospholipid syndrome in an adolescent girl with sjögren syndrome
by: Arockia John, et al.
Published: (2021-01-01)

Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy
by: Ke C, et al.
Published: (2025-02-01)

Psychosis Crisis Associated with Thyrotoxicosis due to Graves’ Disease
by: Lilibet Urias-Uribe, et al.
Published: (2017-01-01)

Graves’ Disease Presenting as a Unilateral Breast Mass
by: Neeka N. Akhavan, et al.
Published: (2022-01-01)

Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases
by: Basveshwar Gawali, et al.
Published: (2025-02-01)

Cerebrovascular Diseases and Risk Factors: a Strategy of Primary Prevention
by: Miguel Angel Buergo Zuaznábar, et al.
Published: (2007-05-01)

Neuroimaging: biochemical principles and its application in the cerebrovascular ischemic disease.
by: Zenaida Milagros Hernández Díaz, et al.
Published: (2009-07-01)

Uric acid levels and their relation to incapacities in acute cerebrovascular disease
by: Julio López Argüelles, et al.
Published: (2010-02-01)

Clinical Report of Probable Catastrophic Antiphospholipid Syndrome in Pregnancy
by: Eryk Hakman, et al.
Published: (2018-01-01)

Seizures in Primary Antiphospholipid Syndrome: The Relevance of Smoking to Stroke
by: Jozélio Freire de Carvalho, et al.
Published: (2012-01-01)

Rheumatic Fever Associated with Antiphospholipid Syndrome: Systematic Review
by: Felipe da Silva, et al.
Published: (2014-01-01)